Medtronic PLC (MDT) Shares Sold by IFC Holdings Incorporated FL
IFC Holdings Incorporated FL trimmed its holdings in shares of Medtronic PLC (NYSE:MDT) by 15.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,805 shares of the medical technology company’s stock after selling 868 shares during the quarter. IFC Holdings Incorporated FL’s holdings in Medtronic were worth $372,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Advantus Capital Management Inc grew its holdings in Medtronic by 0.4% during the 1st quarter. Advantus Capital Management Inc now owns 137,521 shares of the medical technology company’s stock valued at $11,079,000 after purchasing an additional 497 shares during the last quarter. Homrich & Berg grew its holdings in Medtronic by 19.0% during the 1st quarter. Homrich & Berg now owns 4,991 shares of the medical technology company’s stock valued at $402,000 after purchasing an additional 798 shares during the last quarter. Westside Investment Management Inc. grew its holdings in Medtronic by 114.5% during the 1st quarter. Westside Investment Management Inc. now owns 13,476 shares of the medical technology company’s stock valued at $1,081,000 after purchasing an additional 7,193 shares during the last quarter. Israel Discount Bank of New York bought a new position in Medtronic during the 1st quarter valued at about $117,000. Finally, Sentry Investments Corp. grew its holdings in Medtronic by 0.5% during the 1st quarter. Sentry Investments Corp. now owns 1,093,500 shares of the medical technology company’s stock valued at $88,092,000 after purchasing an additional 5,100 shares during the last quarter. Hedge funds and other institutional investors own 81.85% of the company’s stock.
Several brokerages recently commented on MDT. Cowen set a $95.00 price target on shares of Medtronic and gave the company a “buy” rating in a report on Tuesday, August 22nd. Oppenheimer reiterated a “buy” rating and set a $92.00 price target on shares of Medtronic in a report on Tuesday, August 22nd. Royal Bank Of Canada reiterated a “buy” rating and set a $90.00 price target on shares of Medtronic in a report on Monday, August 21st. BidaskClub upgraded shares of Medtronic from a “sell” rating to a “hold” rating in a research note on Friday, August 11th. Finally, Stifel Nicolaus upped their target price on shares of Medtronic from $83.00 to $85.00 and gave the stock a “hold” rating in a research note on Wednesday, November 22nd. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and thirteen have given a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $88.02.
In related news, CEO Omar Ishrak sold 140,407 shares of the stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $81.63, for a total transaction of $11,461,423.41. Following the completion of the sale, the chief executive officer now owns 668,503 shares of the company’s stock, valued at $54,569,899.89. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Bryan C. Hanson sold 16,000 shares of the stock in a transaction that occurred on Thursday, November 16th. The shares were sold at an average price of $79.02, for a total transaction of $1,264,320.00. The disclosure for this sale can be found here. Insiders have sold 172,407 shares of company stock valued at $13,974,223 in the last three months. 0.31% of the stock is currently owned by corporate insiders.
Medtronic PLC (MDT) traded down $0.93 during midday trading on Friday, hitting $80.57. 5,497,500 shares of the stock were exchanged, compared to its average volume of 4,962,533. The company has a current ratio of 2.40, a quick ratio of 2.05 and a debt-to-equity ratio of 0.50. Medtronic PLC has a 1 year low of $69.35 and a 1 year high of $89.72. The company has a market capitalization of $110,310.08, a P/E ratio of 17.57, a PEG ratio of 2.25 and a beta of 1.00.
Medtronic (NYSE:MDT) last posted its earnings results on Tuesday, November 21st. The medical technology company reported $1.07 EPS for the quarter, beating the Zacks’ consensus estimate of $0.99 by $0.08. Medtronic had a net margin of 16.93% and a return on equity of 12.63%. The company had revenue of $7.05 billion during the quarter, compared to analysts’ expectations of $7.05 billion. During the same quarter in the prior year, the company posted $1.12 earnings per share. Medtronic’s revenue for the quarter was down 4.0% compared to the same quarter last year. equities research analysts expect that Medtronic PLC will post 4.77 earnings per share for the current year.
ILLEGAL ACTIVITY NOTICE: This piece was published by Daily Political and is owned by of Daily Political. If you are viewing this piece on another site, it was stolen and republished in violation of US & international copyright and trademark law. The original version of this piece can be read at https://www.dailypolitical.com/2017/12/08/medtronic-plc-mdt-shares-sold-by-ifc-holdings-incorporated-fl.html.
Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.
Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic PLC (NYSE:MDT).
Receive News & Ratings for Medtronic PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic PLC and related companies with MarketBeat.com's FREE daily email newsletter.